Underwrites specialty insurance and reinsurance products in the property and casualty markets. Now — the numbers.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
An average decline of 8% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.
This company is not turning a profit, so the market is pricing its sales instead: 0.8× for every dollar of annual revenue.
Analysts' average target sits 51% above today's price.
The stock trades 51% below its peak. The market has trimmed its expectations for the company.
It pays out $1.24 per share each year — regular cash for whoever holds the stock.
A loss of $158.6M against $1.4B in annual sales. And on top of that, sales fell from the year before.
Over the last 12 months, executives reported 22 sells against just 0 buys. Not an alarm bell by itself, but a number worth watching.
We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the revenue breakdown.